Onco-PDO™, which stands for “Oncology Patient-derived Organoid”, is a revolutionary 3D cell-based scaffolding technology that enables patient-derived cancer cells to be cultured in laboratories, and used for testing against a panel of approved drugs and new drug candidates.


How does it work? A biopsy of the patient tumour is taken from routine surgery and sent for cell culturing in the laboratory, allowing us to eventually obtain the patient’s cancer organoid. After obtaining the organoid, it will be grown as a simulation of the cancer cells. We shall perform drug screening, by adding drugs onto the multi-well plate and culturing them together with the organoid. Once these procedures are done, the Oncologist receives a clinical laboratory report which will yield further insights to decide and prioritise oncological treatment regimens. Click here to download PDF.